Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin add-on treatment for cognitive deficits in schizophrenia
ChiCTR-TRC-14004160Phase 4Completed
- Sponsor
- Beijing Anding Hospital
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Oxytocin group with Placebo group (2 arms). Primary endpoints: PANSS, CGI and 5 more. Started Jan 2014; status: completed.
02
Drugs
oxytocin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-TRC-14004160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004160.